IBM said on Thursday it will spend $240 million over the next decade to fund a new artificial intelligence research lab at the Massachusetts Institute of Technology. The resulting MIT–IBM Watson AI Lab will focus on a handful of key AI areas including the development of new "deep learning" algorithms. Deep learning is a subset of AI that aims to bring human-like learning capabilities to computers so they can operate more autonomously. The Cambridge, Mass.-based lab will be led by Dario Gil, vice president of AI for IBM Research and Anantha Chandrakasan, dean of MIT's engineering school. It will draw upon about 100 researchers from IBM (ibm) itself and the university.
-- Systems powered by artificial intelligence are being developed to be more user - friendly by communicating with users in a progressively "human - like" conversational way. Chatbots, also known as dialogue systems, interactive conversational agents, or virtual agents are an example of such systems used in a wide variety of applications ranging from customer support in the business domain to companionship in the healthcare sector. It is becoming increasingly important to develop chatbots that can best respond to the personalized needs of thei r users, so that they can be as helpful to the user as possible in a real human way. This paper investigates and compare s three popular existing chatbots API offerings and then propose and develop a voice interactive and multilingual chatbot that can effec tively respond to users' mood, tone, and language using IBM Watson Assistant, Tone Analyzer, and Language Translator. The chatbot was evaluated using a use case that was targeted at responding to users' needs regarding exam stress based on university stude nts survey data generated using Google Forms. The results of measuring the chatbot effectiveness at analyzing responses regarding exam stress indicate that the chatbot responding appropriately to the user queries regarding how they are feeling about exams 76.5%. The chatbot could also be adapted for use in other application areas such as student info - centers, government kiosks, and mental health support systems . We have long envisioned that in the near future computers will fully understand natural language, anticipate our needs and proactively complete tasks on our behalf  .
Disruption ahead: Deloitte's point of view on IBM Watson8 9. What makes Watson unique In technical terms, IBM Watson is an advanced open-domain question answering (QA) system with deep natural language processing (NLP) capabilities. At this point, the Watson Software as a Service (SaaS) platform is most effectively used to sift through massive amounts of text--documents, emails, social posts, and more--to answer questions in real time. Watson accepts questions posed by the user in natural language and provides the user with a response (or a set of responses) by generating and evaluating various hypotheses around different interpretations of the question and possible answers to it. Unlike keyword-based search engines, which simply retrieve relevant documents, Watson gleans context from the question to provide the user with precise and relevant answers, along with confidence ratings and supporting evidence. Its learning capabilities allow Watson to adapt and improve hypothesis generation and evaluation processes over time through interactions with users. Developers and other users can improve the accuracy of responses by "training" Watson. IBM is also continuing to expand Watson's capabilities to incorporate visualization, reasoning, ability to relate to users, and deeper exploration to gain a broader understanding of the information content. Watson recently launched a new platform service that has the ability to ingest and interpret still and video images, which is another significant type of unstructured data.
Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant. "It is designed for people who are currently using Guardian Connect; so made for people on multiple daily injections. It is a personal assistant a little bit like Alexa or Siri," Huzefa Neemuchwala, global head of digital health solutions and AI at Medtronic, said in a Facebook live informational session. "It is an intelligent assistant that keeps track of all of your information and has all of your information in one place. Then through Watson technology we use this information to power insights so we can better manage your diabetes so that you can spend more time in range."
IBM Watson Health has formed a medical imaging collaborative with more than 15 leading healthcare organizations. The goal: To take on some of the most deadly diseases. The collaborative, which includes health systems, academic medical centers, ambulatory radiology providers and imaging technology companies, aims to help doctors address breast, lung, and other cancers; diabetes; eye health; brain disease; and heart disease and related conditions, such as stroke. Watson will mine insights from what IBM calls previously invisible unstructured imaging data and combine it with a broad variety of data from other sources, such as data from electronic health records, radiology and pathology reports, lab results, doctors' progress notes, medical journals, clinical care guidelines and published outcomes studies. As the work of the collaborative evolves, Watson's rationale and insights will evolve, informed by the latest combined thinking of the participating organizations.